Trametinib downregulates survivin expression in RB1-positive KRAS -mutant lung adenocarcinoma cells

This publication has 24 references indexed in Scilit:

• Transcriptional regulation of the survivin gene
  Molecular Biology Reports, 2013
• Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells
  Laboratory Investigation, 2013
• Compensatory Pathways Induced by MEK Inhibition Are Effective Drug Targets for Combination Therapy against Castration-Resistant Prostate Cancer
  Molecular Cancer Therapeutics, 2011
• Emerging roles of E2Fs in cancer: an exit from cell cycle control
  Nature Reviews Cancer, 2009
• Survivin repression by p53, Rb and E2F2 in normal human melanocytes
  Carcinogenesis, 2007
• p21Waf1/Cip1/Sdi1 mediates retinoblastoma protein degradation
  Oncogene, 2007
• Aberrant Regulation of Survivin by the RB/E2F Family of Proteins
  Journal of Biological Chemistry, 2004
• Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras
  Oncogene, 2004
• IFN‐γ inducibility of class II transactivator is specifically lacking in human tumour lines: Relevance to retinoblastoma protein rescue of IFN‐γ inducibility of the HLA class II genes
  Immunology & Cell Biology, 1997
• Regulation of E2F through ubiquitin–proteasome-dependent degradation: Stabilization by the pRB tumor suppressor protein
  Proceedings of the National Academy of Sciences, 1997